Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million
Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised $625 million in an upsized initial public offering, marking […]
Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million Read Post »
